Bellerophon Therapeutics Inc (BLPH) - Financial Analysis Review - GlobalData - Company Reports

Bellerophon Therapeutics Inc (BLPH) - Financial Analysis Review

Bellerophon Therapeutics Inc (BLPH) - Financial Analysis Review - GlobalData - Company Reports
Bellerophon Therapeutics Inc (BLPH) - Financial Analysis Review
Published Nov 29, 2016
35 pages — Published Nov 29, 2016
Price US$ 125.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly known as Bellerophon Therapeutics LLC, focuses on the development of products with the combination of drugs and devices for the treatment of cardiopulmonary diseases. The company pipeline portfolio offers product candidates for the treatment of pulmonary arterial hypertension (PAH), pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD), and pulmonary hypertension associated with idiopathic pulmonary fibrosis (PH-IPF). It develops products using INOpulse program, a proprietary pulsatile nitric oxide delivery device.

GlobalData's Bellerophon Therapeutics Inc (BLPH) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Bellerophon Therapeutics Inc Key Recent Developments:

Nov 08,2016: Bellerophon Reports Third Quarter 2016 Financial Results and Provides Business Update
Sep 20,2016: Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016
Aug 09,2016: Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update
May 10,2016: Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update
Mar 21,2016: Bellerophon Reports 2015 Financial Results and Provides Business Update


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

  
Source:
Document ID
GDPH512312FA
Country
Industry
Ticker
BLPH=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Section 1 - About the Company41
Bellerophon Therapeutics Inc - Key Facts51
Bellerophon Therapeutics Inc - Key Employees61
Bellerophon Therapeutics Inc - Major Products and Services71
Bellerophon Therapeutics Inc - History81
Bellerophon Therapeutics Inc - Locations And Subsidiaries91
  Head Office91
Section 2 Company Analysis101
Company Overview101
Bellerophon Therapeutics Inc - Key Competitors111
Section 3 Company Financial Ratios121
Financial Ratios - Capital Market Ratios121
Financial Ratios - Annual Ratios131
Performance Chart141
Financial Performance141
Financial Ratios - Interim Ratios151
Financial Ratios - Ratio Charts161
Section 4 Company s Lifesciences Financial Deals and Alliances172
  Bellerophon Therapeutics Inc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016171
  Bellerophon Therapeutics Inc, Pharmaceuticals &Healthcare, Deals By Type, 2010 to YTD 2016181
Bellerophon Therapeutics Inc, Recent Deals Summary191
Section 5 Company s Recent Developments201
Nov 08, 2016: Bellerophon Reports Third Quarter 2016 Financial Results and Provides Business Update201
Sep 20, 2016: Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016211
Aug 09, 2016: Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update221
May 10, 2016: Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update231
Mar 21, 2016: Bellerophon Reports 2015 Financial Results and Provides Business Update242
Mar 02, 2016: Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)261
Feb 23, 2016: Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer271
Feb 16, 2016: Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member281
Nov 12, 2015: Bellerophon Reports 2015 Third Quarter Operational and Financial Results291
Sep 15, 2015: Bellerophon Therapeutics Announces Leadership Team Changes301
Section 6 Appendix315
  Methodology311
  Ratio Definitions314
  About GlobalData351
  Contact Us351
  Disclaimer351

Table Of Contents

GlobalData - Company Reports—GlobalData is an industry analysis specialist, providing business information products and services. These high quality company reports are created via a large research and analysis capability, drawing from extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
GlobalData - Company Reports. "Bellerophon Therapeutics Inc (BLPH) - Financial Analysis Review" Nov 29, 2016. Alacra Store. Sep 20, 2019. <http://www.alacrastore.com/storecontent/GlobalData-Company-Reports/Bellerophon-Therapeutics-Inc-BLPH-Financial-Analysis-Review-2087-64709>
  
APA:
GlobalData - Company Reports. (2016). Bellerophon Therapeutics Inc (BLPH) - Financial Analysis Review Nov 29, 2016. New York, NY: Alacra Store. Retrieved Sep 20, 2019 from <http://www.alacrastore.com/storecontent/GlobalData-Company-Reports/Bellerophon-Therapeutics-Inc-BLPH-Financial-Analysis-Review-2087-64709>
  
US$ 125.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.